Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3232597198;97199;97200 chr2:178542881;178542880;178542879chr2:179407608;179407607;179407606
N2AB3068492275;92276;92277 chr2:178542881;178542880;178542879chr2:179407608;179407607;179407606
N2A2975789494;89495;89496 chr2:178542881;178542880;178542879chr2:179407608;179407607;179407606
N2B2326070003;70004;70005 chr2:178542881;178542880;178542879chr2:179407608;179407607;179407606
Novex-12338570378;70379;70380 chr2:178542881;178542880;178542879chr2:179407608;179407607;179407606
Novex-22345270579;70580;70581 chr2:178542881;178542880;178542879chr2:179407608;179407607;179407606
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAG
  • RefSeq wild type template codon: CTC
  • Domain: Ig-154
  • Domain position: 19
  • Structural Position: 29
  • Q(SASA): 0.5163
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/Q rs1196060333 -0.087 0.994 N 0.598 0.208 0.19670166235 gnomAD-2.1.1 4.04E-06 None None None None N None 0 0 None 0 0 None 0 None 0 8.96E-06 0
E/Q rs1196060333 -0.087 0.994 N 0.598 0.208 0.19670166235 gnomAD-4.0.0 2.7371E-06 None None None None N None 0 0 None 0 0 None 0 0 3.59831E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.2251 likely_benign 0.2069 benign -0.596 Destabilizing 0.961 D 0.594 neutral N 0.488974253 None None N
E/C 0.8658 likely_pathogenic 0.8569 pathogenic -0.363 Destabilizing 1.0 D 0.7 prob.neutral None None None None N
E/D 0.1981 likely_benign 0.1836 benign -0.797 Destabilizing 0.031 N 0.248 neutral N 0.508349448 None None N
E/F 0.8125 likely_pathogenic 0.7857 pathogenic -0.006 Destabilizing 0.996 D 0.702 prob.neutral None None None None N
E/G 0.3689 ambiguous 0.3406 ambiguous -0.922 Destabilizing 0.98 D 0.601 neutral N 0.459161608 None None N
E/H 0.5035 ambiguous 0.4575 ambiguous -0.033 Destabilizing 1.0 D 0.6 neutral None None None None N
E/I 0.3852 ambiguous 0.3606 ambiguous 0.279 Stabilizing 0.983 D 0.651 neutral None None None None N
E/K 0.2957 likely_benign 0.2657 benign -0.232 Destabilizing 0.98 D 0.588 neutral N 0.45093594 None None N
E/L 0.4886 ambiguous 0.4484 ambiguous 0.279 Stabilizing 0.942 D 0.617 neutral None None None None N
E/M 0.5096 ambiguous 0.4742 ambiguous 0.459 Stabilizing 0.999 D 0.679 prob.neutral None None None None N
E/N 0.3331 likely_benign 0.3112 benign -0.769 Destabilizing 0.991 D 0.587 neutral None None None None N
E/P 0.8813 likely_pathogenic 0.8702 pathogenic 0.009 Stabilizing 0.999 D 0.678 prob.neutral None None None None N
E/Q 0.1575 likely_benign 0.1489 benign -0.643 Destabilizing 0.994 D 0.598 neutral N 0.476045028 None None N
E/R 0.4134 ambiguous 0.3828 ambiguous 0.121 Stabilizing 0.996 D 0.613 neutral None None None None N
E/S 0.2333 likely_benign 0.2116 benign -0.996 Destabilizing 0.97 D 0.562 neutral None None None None N
E/T 0.2017 likely_benign 0.1984 benign -0.724 Destabilizing 0.97 D 0.599 neutral None None None None N
E/V 0.2258 likely_benign 0.2109 benign 0.009 Stabilizing 0.433 N 0.452 neutral N 0.44989579 None None N
E/W 0.9496 likely_pathogenic 0.934 pathogenic 0.258 Stabilizing 1.0 D 0.669 neutral None None None None N
E/Y 0.7521 likely_pathogenic 0.7004 pathogenic 0.254 Stabilizing 0.999 D 0.695 prob.neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.